Blalock-Taussig shunt: Difference between revisions

Jump to navigation Jump to search
Line 3: Line 3:
<br />
<br />
==Overview==
==Overview==
The '''Blalock-Taussig shunt''' is a surgical procedure to give palliation to [[cyanotic heart defect]]s which are common causes of [[blue baby syndrome]]. In modern surgery, this procedure is temporarily used to direct blood flow to the lungs and relieve cyanosis while the infant is waiting for corrective surgery.One branch of the [[subclavian artery]] (Arteria subclavia) or [[carotid artery]] (Arteria carotis) is separated and connected with the [[pulmonary artery]] (Arteria pulmonalis). The [[Human lung|lung]] receives more blood with low [[oxygenation]] from the body. The first area of application was [[tetralogy of Fallot]]. This procedure has been modified into modified Blalock-Taussing Shunt (mBTS). In this modified procedure a graft from innominate artery or subclavian artery is placed to the corresponding pulmonary artery.   
The '''Blalock-Taussig shunt''' is a surgical procedure that are done as palliative procedures for [[cyanotic heart defect]]s which are common causes of [[blue baby syndrome]]. In modern surgery, this procedure is temporarily used to direct blood flow to the lungs and relieve cyanosis while the infant is waiting for corrective surgery. One branch of the [[subclavian artery]] (Arteria subclavia) or [[carotid artery]] (Arteria carotis) is separated and connected with the [[pulmonary artery]] (Arteria pulmonalis). The [[Human lung|lung]] receives more blood with low [[oxygenation]] from the body. The first area of application was [[tetralogy of Fallot]]. This procedure has been modified into modified Blalock-Taussing Shunt (mBTS). In this modified procedure a graft from innominate artery or subclavian artery is placed to the corresponding pulmonary artery.   


== Historical Prospective ==
== Historical Prospective ==
Line 9: Line 9:
The original procedure was named for Alfred Blalock, surgeon, Baltimore, (1899–1964) and [[Helen B. Taussig]], cardiologist, Baltimore/Boston, (1898–1986) who, along with Blalock's African American laboratory technician [[Vivien Thomas]] (1910–1985), developed the procedure. Taussig, who treated hundreds of infants and children with this disorder, had observed that children with a cyanotic heart defect and a [[patent ductus arteriosus]] (PDA) lived longer than those without the PDA. It therefore seemed to her that a shunt which mimicked the function of a PDA might relieve the tetralogy patients' poor oxygenation. In 1943, having broached the possibility of a surgical solution to Dr. Robert Gross of Boston without success, Dr. Taussig approached Blalock and Thomas in their Hopkins laboratory in 1943.  
The original procedure was named for Alfred Blalock, surgeon, Baltimore, (1899–1964) and [[Helen B. Taussig]], cardiologist, Baltimore/Boston, (1898–1986) who, along with Blalock's African American laboratory technician [[Vivien Thomas]] (1910–1985), developed the procedure. Taussig, who treated hundreds of infants and children with this disorder, had observed that children with a cyanotic heart defect and a [[patent ductus arteriosus]] (PDA) lived longer than those without the PDA. It therefore seemed to her that a shunt which mimicked the function of a PDA might relieve the tetralogy patients' poor oxygenation. In 1943, having broached the possibility of a surgical solution to Dr. Robert Gross of Boston without success, Dr. Taussig approached Blalock and Thomas in their Hopkins laboratory in 1943.  


The original procedure was named for [[Alfred Blalock]], surgeon, Baltimore, (1899–1964) and [[Helen B. Taussig]], cardiologist, Baltimore/Boston, (1898–1986) who, along with Blalock's African American laboratory technician [[Vivien Thomas]] (1910–1985), developed the procedure. Taussig, who treated hundreds of infants and children with this disorder, had observed that children with a cyanotic heart defect and a [[patent ductus arteriosus]] (PDA) lived longer than those without the PDA. It therefore seemed to her that a shunt which mimicked the function of a PDA might relieve the tetralogy patients' poor oxygenation. In 1943, having broached the possibility of a surgical solution to Dr. Robert Gross of Boston  without success, Dr. Taussig approached Blalock and Thomas in their Hopkins laboratory in 1943.  
The original procedure was named for [[Alfred Blalock]], surgeon, Baltimore, (1899–1964) and [[Helen B. Taussig]], cardiologist, Baltimore/Boston, (1898–1986) who, along with Blalock's African American laboratory technician [[Vivien Thomas]] (1910–1985), developed the procedure. Taussig, who treated hundreds of infants and children with this disorder, had observed that children with a cyanotic heart defect and a [[patent ductus arteriosus]] (PDA) lived longer than those without the PDA. It therefore seemed to her that a shunt which mimicked the function of a PDA might relieve the tetralogy patients' poor oxygenation. In 1943, having broached the possibility of a surgical solution to Dr. Robert Gross of Boston  without success, Dr. Taussig approached Blalock and Thomas in their Hopkins laboratory in 1943. [[File:Modified-blalock-taussig-shunt-creative-commons.png|left|thumb|277x277px|'''Modified Blalock-Taussig shunt diagram Case courtesy of Dr Laurent Bilodeau,"https://radiopaedia.org/".From the case https://radiopaedia.org/cases/74773 ,rID: 74773''']]


=== Modified Blalock-Taussig Shunt ===
=== Modified Blalock-Taussig Shunt ===
A modified method of inserting a shunt was developed in 1962  by Klinner using teflon as prosthetic graft material between the subclavian artery and the pulmonary artery is used to prevent scarring of the subclavian arter.<ref name="pmid14457041">{{cite journal| author=KLINNER W, PASINI M, SCHAUDIG A| title=[Anastomosis between systemic and pulmonary arteries with the aid of plastic prostheses in cyanotic heart diseases]. | journal=Thoraxchirurgie | year= 1962 | volume= 10 | issue=  | pages= 68-75 | pmid=14457041 | doi=10.1055/s-0028-1096482 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14457041  }} </ref>
A modified method of inserting a shunt was developed in 1962  by Klinner using teflon as prosthetic graft material between the subclavian artery and the pulmonary artery is used to prevent scarring of the subclavian arter.


<br />
<br />
[[File:Modified-blalock-taussig-shunt-creative-commons.png|left|thumb|347.981x347.981px|'''Modified Blalock-Taussig shunt diagram Case courtesy of Dr Laurent Bilodeau,"https://radiopaedia.org/".From the case https://radiopaedia.org/cases/74773 ,rID: 74773''']]


<br />
==  References ==
==  References ==
<references />{{Cardiac surgery and other cardiovascular procedures}}
<references />{{Cardiac surgery and other cardiovascular procedures}}

Revision as of 19:12, 5 June 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

WikiDoc Resources for Blalock-Taussig shunt

Articles

Most recent articles on Blalock-Taussig shunt

Most cited articles on Blalock-Taussig shunt

Review articles on Blalock-Taussig shunt

Articles on Blalock-Taussig shunt in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Blalock-Taussig shunt

Images of Blalock-Taussig shunt

Photos of Blalock-Taussig shunt

Podcasts & MP3s on Blalock-Taussig shunt

Videos on Blalock-Taussig shunt

Evidence Based Medicine

Cochrane Collaboration on Blalock-Taussig shunt

Bandolier on Blalock-Taussig shunt

TRIP on Blalock-Taussig shunt

Clinical Trials

Ongoing Trials on Blalock-Taussig shunt at Clinical Trials.gov

Trial results on Blalock-Taussig shunt

Clinical Trials on Blalock-Taussig shunt at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Blalock-Taussig shunt

NICE Guidance on Blalock-Taussig shunt

NHS PRODIGY Guidance

FDA on Blalock-Taussig shunt

CDC on Blalock-Taussig shunt

Books

Books on Blalock-Taussig shunt

News

Blalock-Taussig shunt in the news

Be alerted to news on Blalock-Taussig shunt

News trends on Blalock-Taussig shunt

Commentary

Blogs on Blalock-Taussig shunt

Definitions

Definitions of Blalock-Taussig shunt

Patient Resources / Community

Patient resources on Blalock-Taussig shunt

Discussion groups on Blalock-Taussig shunt

Patient Handouts on Blalock-Taussig shunt

Directions to Hospitals Treating Blalock-Taussig shunt

Risk calculators and risk factors for Blalock-Taussig shunt

Healthcare Provider Resources

Symptoms of Blalock-Taussig shunt

Causes & Risk Factors for Blalock-Taussig shunt

Diagnostic studies for Blalock-Taussig shunt

Treatment of Blalock-Taussig shunt

Continuing Medical Education (CME)

CME Programs on Blalock-Taussig shunt

International

Blalock-Taussig shunt en Espanol

Blalock-Taussig shunt en Francais

Business

Blalock-Taussig shunt in the Marketplace

Patents on Blalock-Taussig shunt

Experimental / Informatics

List of terms related to Blalock-Taussig shunt


Overview

The Blalock-Taussig shunt is a surgical procedure that are done as palliative procedures for cyanotic heart defects which are common causes of blue baby syndrome. In modern surgery, this procedure is temporarily used to direct blood flow to the lungs and relieve cyanosis while the infant is waiting for corrective surgery. One branch of the subclavian artery (Arteria subclavia) or carotid artery (Arteria carotis) is separated and connected with the pulmonary artery (Arteria pulmonalis). The lung receives more blood with low oxygenation from the body. The first area of application was tetralogy of Fallot. This procedure has been modified into modified Blalock-Taussing Shunt (mBTS). In this modified procedure a graft from innominate artery or subclavian artery is placed to the corresponding pulmonary artery.

Historical Prospective

Original Blalock-Taussig shunt diagram,Case courtesy of Dr Laurent Bilodeau, https://radiopaedia.org/cases/74774">rID: 74774

The original procedure was named for Alfred Blalock, surgeon, Baltimore, (1899–1964) and Helen B. Taussig, cardiologist, Baltimore/Boston, (1898–1986) who, along with Blalock's African American laboratory technician Vivien Thomas (1910–1985), developed the procedure. Taussig, who treated hundreds of infants and children with this disorder, had observed that children with a cyanotic heart defect and a patent ductus arteriosus (PDA) lived longer than those without the PDA. It therefore seemed to her that a shunt which mimicked the function of a PDA might relieve the tetralogy patients' poor oxygenation. In 1943, having broached the possibility of a surgical solution to Dr. Robert Gross of Boston without success, Dr. Taussig approached Blalock and Thomas in their Hopkins laboratory in 1943.

The original procedure was named for Alfred Blalock, surgeon, Baltimore, (1899–1964) and Helen B. Taussig, cardiologist, Baltimore/Boston, (1898–1986) who, along with Blalock's African American laboratory technician Vivien Thomas (1910–1985), developed the procedure. Taussig, who treated hundreds of infants and children with this disorder, had observed that children with a cyanotic heart defect and a patent ductus arteriosus (PDA) lived longer than those without the PDA. It therefore seemed to her that a shunt which mimicked the function of a PDA might relieve the tetralogy patients' poor oxygenation. In 1943, having broached the possibility of a surgical solution to Dr. Robert Gross of Boston without success, Dr. Taussig approached Blalock and Thomas in their Hopkins laboratory in 1943.

Modified Blalock-Taussig shunt diagram Case courtesy of Dr Laurent Bilodeau,"https://radiopaedia.org/".From the case https://radiopaedia.org/cases/74773 ,rID: 74773

Modified Blalock-Taussig Shunt

A modified method of inserting a shunt was developed in 1962 by Klinner using teflon as prosthetic graft material between the subclavian artery and the pulmonary artery is used to prevent scarring of the subclavian arter.











References

Template:Cardiac surgery and other cardiovascular procedures

de:Blalock-Taussig-Anastomose uk:Анастомоз Блелока-Тауссіга


Template:WikiDoc Sources CME Category::Cardiology